Epegis
Specifications
- Manufacturer
Branch of Agimexpharm Pharmaceutical JSC. - Agimexpharm Pharmaceutical Factory
Vu Trong Phung Street, Thanh An Hamlet, My Thoi Ward, Long Xuyen City, An Giang Province, Viet Nam- Applicant company
Agimexpharm Pharmaceutical Joint Stock Company
27 Nguyen Thai Hoc Street, My Binh Ward, Long Xuyen City, An Giang Province, Viet Nam- Active ingredient
Eperisone hydrochloride
- Content
50mg
- Shelf life
36 months
- Dosage Form
Film-coated tablets
- Package
Box of 3 blisters of 10 film-coated tablets
- Visa Number
893110430524
- Issuing Date
28/06/2024
- Therapeutic area
Muscle relaxants and muscle tone enhancers
- Indication
Improvement of myotonic symptoms associated with the following diseases: Cervical syndrome, periarthritis of the shoulder and lumbago.
Spastic paralysis associated with the following diseases: Cerebrovascular diseases, spastic spinal paralysis, cervical spondylosis, postoperative sequelae (including cerebrospinal tumor), sequelae to trauma (spinal trauma, head injury), amyotrophic lateral sclerosis, cerebral palsy, spinocerebellar degenaration, spinal vascular diseases and other encephalomyelopathies- Dosage
In adults, the usual dose is one tablet once, three times daily.
The dosage should be adjusted depending on patient's age and severity of the symptoms.
